Table 3. Relationships between the expressions of the immune-related genes and the clinicopathological factors in papillary thyroid cancer.
| Genes | Age (≥60/ <60) |
Gender (male/ female) |
Tumor status (with tumor/ tumor free) |
Primary neoplasm focus type (multifocal/ unifocal) |
Pathological stage (IV–III/ I–II) |
T stage (T3–T4/ T1–T2) |
N stage (N1–3/ N0) |
M stage (M1/ M0) |
| t | P | t | P | t | P | t | P | t | P | t | P | t | P | t | P | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AGTR1 | -0.422 | 0.673 | -2.103 | 0.036 | -2.145 | 0.032 | 3.444 | 0.001 | -3.615 | <0.001 | -4.832 | <0.001 | -5.088 | <0.001 | -3.861 | <0.001 |
| CTGF | -0.513 | 0.608 | -0.895 | 0.371 | -0.105 | 0.916 | 1.010 | 0.313 | -0.405 | 0.686 | -0.853 | 0.394 | 1.288 | 0.198 | -1.237 | 0.217 |
| FAM3B | -0.214 | 0.831 | -1.261 | 0.208 | -2.667 | 0.008 | 0.547 | 0.584 | 0.272 | 0.786 | 0.225 | 0.822 | 0.987 | 0.324 | -1.589 | 0.113 |
| IL11 | 1.340 | 0.182 | 1.377 | 0.169 | 3.212 | 0.002 | -0.510 | 0.610 | 3.652 | <0.001 | 3.580 | <0.001 | 5.146 | <0.001 | 1.880 | 0.096 |
| IL17C | 0.878 | 0.380 | 1.260 | 0.208 | 2.144 | 0.037 | -2.431 | 0.015 | 3.746 | <0.001 | 3.918 | <0.001 | 4.199 | <0.001 | 0.899 | 0.370 |
| PTH2R | -2.093 | 0.037 | 0.481 | 0.631 | -2.729 | 0.007 | -0.125 | 0.901 | -1.480 | 0.140 | 0.121 | 0.904 | 1.968 | 0.050 | -0.538 | 0.591 |
| SPAG11A | -2.551 | 0.013 | 1.884 | 0.061 | -0.198 | 0.843 | 1.025 | 0.306 | -1.587 | 0.113 | -0.586 | 0.558 | 0.756 | 0.450 | -0.153 | 0.879 |
Note: t: t value of student's t test; P: P-value of student's t test.